AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · IEX Real-Time Price · USD
2.250
-0.310 (-12.11%)
At close: Jul 19, 2024, 4:00 PM
2.340
+0.090 (4.00%)
Pre-market: Jul 22, 2024, 7:38 AM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $88.81 million as of July 22, 2024. Its market cap has increased by 37.90% in one year.
Market Cap
88.81M
Enterprise Value
83.65M
1-Year Change
37.90%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since February 9, 2021, AEON Biopharma's market cap has decreased from $259.00M to $88.81M, a decrease of -65.71%. That is a compound annual growth rate of -26.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 88.00M | -67.10% |
| Dec 29, 2023 | 267.50M | -22.84% |
| Dec 30, 2022 | 346.70M | 3.49% |
| Dec 31, 2021 | 335.00M | 29.34% |
| Feb 9, 2021 | 259.00M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LakeShore Biopharma | 92.26M |
| Eupraxia Pharmaceuticals | 91.19M |
| Cellectar Biosciences | 90.34M |
| Eton Pharmaceuticals | 89.92M |
| InflaRx | 89.50M |
| BeyondSpring | 88.66M |
| Alpha Teknova | 88.59M |
| HilleVax | 88.01M |